Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Stokx, Jocelijn ^a   Gillet, Philippe ^a   De Weggheleire, Anja ^b   Casas, Esther C ^a   Maendaenda, Rosa ^b   Beulane, Adelino J ^b   Jani, Ilhes V ^c   Kidane, Solon ^a   Mosse, Carla D ^d   Jacobs, Jan ^a   Bottieau, Emmanuel ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Provincial Hospital of Tete (PHT)   (Mozambique)

^c Institut Nacional da Saude   (Mozambique)

^d Direcçao Provincial da Saude ^*  (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD EXAMINATION; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; HEALTH BEHAVIOR; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROPREVALENCE; SYPHILIS; ADOLESCENT; BELGIUM; BLOOD; BLOOD SAFETY; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; EPIDEMIOLOGY; HOSPITAL; ISOLATION AND PURIFICATION; MASS SCREENING; PREVALENCE; STANDARD;

ADOLESCENT; ADULT; BELGIUM; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HOSPITALS; HUMANS; MALE; MASS SCREENING; MOZAMBIQUE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SYPHILIS; YOUNG ADULT;

EID: 79956200597     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-141     Document Type: Article

References (30)

1. World Health Organization Universal access to safe blood transfusion. 2008, World Health Organization, Geneva, World Health Organization.
2. World Health Organization Aide-mémoire: Blood safety. 2002, World Health Organization, Geneva, World Health Organization.
3. Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol 2007, 14:671-676.
4. Maresch C, Schluter PJ, Wilson AD, Sleigh A. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil. Transfusion 2008, 48:273-281.
5. Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 2010, 50:433-442. 10.1111/j.1537-2995.2009.002402.x, 19843290.
6. Tagny CT, Mbanya D, Tapko JB, Lefrere JJ. Blood safety in Sub-Saharan Africa: a multi-factorial problem. Transfusion 2008, 48:1256-1261. 10.1111/j.1537-2995.2008.01697.x, 18713111.
7. Field SP, Allain JP. Transfusion in sub-Saharan Africa: does a Western model fit?. J Clin Pathol 2007, 60:1073-1075. 10.1136/jcp.2006.043505, 2014840, 17412874.
8. El Ekiaby M, Lelie N, Allain JP. Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals 2010, 38:59-64. 10.1016/j.biologicals.2009.10.015, 20079664.
9. Allain JP, Lee H. Rapid tests for detection of viral markers in blood transfusion. Expert Rev Mol Diagn 2005, 5:31-41. 10.1586/14737159.5.1.31, 15723590.
10. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005, 45:133-140. 10.1111/j.1537-2995.2004.04279.x, 15660820.
11. Laperche S, Boukatou G, Kouegnigan L, Nebie Y, Boulahi MO, Tagny CT, Yahaya R, Tapko JB, Murphy E, Lefrere JJ. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion 2009, 49:1600-1608. 10.1111/j.1537-2995.2009.02239.x, 19527479.
12. Allain JP, Opare-Sem O, Sarkodie F, Rahman R, Owusu-Ofori S. Deferred donor care in a regional hospital blood center in Ghana. Transfusion 2009, 49:669-675. 10.1111/j.1537-2995.2008.02055.x, 19170991.
13. Ministry of Health of Mozambique HIV and syphilis epidemiological data surveillance. Ronda Epidemiologica 2007, Ministry of Health of Mozambique.
14. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, . STROBE Initiative Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Medicine 2007, 4:e297. 10.1371/journal.pmed.0040297, 2020496, 17941715, STROBE Initiative.
15. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The Standards for Reporting of Diagnostic Accuracy Group. Croat Med J 2003, 44:639-650.
16. Gie RP, Matiru RH. Supplying quality-assured child-friendly anti-tuberculosis drugs to children. Int J Tuberc Lung Dis 2009, 13:277-278.
17. World Health Organization HIV Rapid Assays: Operational Characteristics. World Health Organization Report 16 2009, World Health Organization.
18. Plate DK. Evaluation and implementation of rapid HIV tests: the experience in 11 African countries. AIDS Res Hum Retroviruses 2007, 23:1491-1498. 10.1089/aid.2007.0020, 18160006.
19. World Health Organization Hepatitis B Assays: Operational Characteristics. World Health Organization Report 1 & 2 2004, World Health Organization.
20. Cunha L, Plouzeau C, Ingrand P, Gudo JP, Ingrand I, Mondlane J, Beauchant M, Agius G. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol 2007, 79:1832-1840. 10.1002/jmv.21010, 17935167.
21. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002, 2:293-302. 10.1016/S1473-3099(02)00264-5, 12062995.
22. Ministry of Health of Mozambique Inquérito Nacional de Prevalência Riscos Comportamentais e Informação sobre o HIV e SIDA em Moçambique. INSIDA 2009, Ministry of Health of Mozambique.
23. Candotti D, Mundy C, Kadewele G, Nkhoma W, Bates I, Allain JP. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses. J Med Virol 2001, 65:1-5. 10.1002/jmv.1093, 11505436.
24. Peeling RW, Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: An overview. Bull World Health Organ 2004, 82:439-446. 2622868, 15356937.
25. Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 2006, 11:951-954. 10.1111/j.1365-3156.2006.01643.x, 16772018.
26. Cancre N, Bois F, Gresenguet G, Fretz C, Fournel JJ, Belec L. Screening blood donations for hepatitis C in Central Africa: analysis of a risk- and cost-based decision tree. Med Decis Making 1999, 19:296-306. 10.1177/0272989X9901900308, 10424836.
27. Kania D, Sangare L, Sakande J, Koanda A, Nebie YK, Zerbo O, Combassere AW, Guissou IP, Rouet F. A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso. Transfusion 2009, 49:2237-2240. 10.1111/j.1537-2995.2009.02276.x, 19903285.
28. Bates I, Manyasi G, Medina LA. Reducing replacement donors in Sub-Saharan Africa: challenges and affordability. Transfus Med 2007, 17:434-442. 10.1111/j.1365-3148.2007.00798.x, 18067647.
29. Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006, 6:21. 10.1186/1471-2458-6-21, 1373616, 16445860.
30. Diarra A, Kouriba B, Baby M, Murphy E, Lefrere JJ. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol 2009, 16:444-447. 10.1016/j.tracli.2009.09.004, 19896404.